Skip to Content
Merck
CN

A9295

4-Androsten-4-ol-3,17-dione acetate

Synonym(s):

4-Acetoxy-4-androstene-3,17-dione

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C21H28O4
CAS Number:
Molecular Weight:
344.44
UNSPSC Code:
12352202
PubChem Substance ID:
MDL number:
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

solid

shipped in

ambient

storage temp.

2-8°C

SMILES string

CC(=O)OC1=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CCC1=O

InChI

1S/C21H28O4/c1-12(22)25-19-16-5-4-13-14-6-7-18(24)21(14,3)10-8-15(13)20(16,2)11-9-17(19)23/h13-15H,4-11H2,1-3H3/t13-,14-,15-,20+,21-/m0/s1

InChI key

LRXSFNGKRCOHRS-VMRCMBGLSA-N



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Recent advances in studies on estrogen biosynthesis.
A M Brodie
Journal of endocrinological investigation, 2(4), 445-460 (1979-10-01)
A M Brodie et al.
Cancer research, 42(8 Suppl), 3360s-3364s (1982-08-01)
Aromatase inhibitor, 4-hydroxyandrostene-3,17-dione (4-OHA), is a highly effective treatment in rats with 7,12-dimethylbenz(a) anthracene-induced hormone-dependent mammary tumors. Over 90% of tumors regress to less than one-half of their original size, and a high proportion regress completely. Treatment of rats with
A M Brodie et al.
Steroids, 38(6), 693-702 (1981-12-01)
4-Hydroxy-4-androstene-3,17-dione (4-OHA) and 4-acetoxy-4-androstene-3,17-dione (4-AcA), in addition to being competitive inhibitors of aromatase, cause time-dependent, irreversible, loss of enzyme activity in both human placental and rat ovarian microsomes. In vivo, treatment of rats with 4-OHA also causes loss of ovarian